Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Alb

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Blood|November 15, 2014
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapyMathias Lutz, Andrea Worschech, Miriam Alb, et al.
Cell Stem Cell|May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cellsTengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Journal of Immunotoxicology|December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assayThuvan Dinh-Le, John Escobar, Louis Poisson, et al.
ALTEX|April 18, 2020
Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeuticsJulia Wallstabe, Lydia Bussemer, Florian Groeber-Becker, et al.
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Blood Advances|April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cellsBettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Hemasphere|December 10, 2025
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapyLukas Scheller, Xiang Zhou, Henry Loeffler-Wirth, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood|November 15, 2014
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapyMathias Lutz, Andrea Worschech, Miriam Alb, et al.
Cell Stem Cell|May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cellsTengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Journal of Immunotoxicology|December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assayThuvan Dinh-Le, John Escobar, Louis Poisson, et al.
ALTEX|April 18, 2020
Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeuticsJulia Wallstabe, Lydia Bussemer, Florian Groeber-Becker, et al.
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Frontiers in Immunology|August 27, 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapiesAlexander Mazein, Oxana Lopata, Kristin Reiche, et al.
Blood Advances|April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cellsBettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Hemasphere|December 10, 2025
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapyLukas Scheller, Xiang Zhou, Henry Loeffler-Wirth, et al.
Pageof 3